Akari Therapeutics Plc Stock Price on September 6, 2024
| AKTX Stock | USD 1.14 0.11 10.68% |
Below is the normalized historical share price chart for Akari Therapeutics PLC extending back to May 07, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Akari Therapeutics stands at 1.14, as last reported on the 26th of November, with the highest price reaching 1.19 and the lowest price hitting 0.90 during the day.
If you're considering investing in Akari Stock, it is important to understand the factors that can impact its price. Akari Therapeutics PLC secures Sharpe Ratio (or Efficiency) of -0.23, which signifies that the company had a -0.23% return per unit of standard deviation over the last 3 months. Akari Therapeutics PLC exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Akari Therapeutics' risk adjusted performance of (0.19), and Mean Deviation of 4.45 to double-check the risk estimate we provide.
At this time, Akari Therapeutics' Stock Based Compensation is fairly stable compared to the past year. Sale Purchase Of Stock is likely to rise to about 16.9 M in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 4.7 M in 2024. . Price Earnings Ratio is likely to drop to -1.6 in 2024. Price Book Value Ratio is likely to rise to -63.35 in 2024. Akari Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 21st of September 2015 | 200 Day MA 2.5482 | 50 Day MA 2.6737 | Beta 0.951 |
Akari |
Sharpe Ratio = -0.2294
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AKTX |
Estimated Market Risk
| 6.97 actual daily | 62 62% of assets are less volatile |
Expected Return
| -1.6 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.23 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Akari Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Akari Therapeutics by adding Akari Therapeutics to a well-diversified portfolio.
Price Book 3.0692 | Book Value (0.04) | Enterprise Value 24.3 M | Enterprise Value Ebitda (0.06) | Shares Float 10.5 B |
Related Headline
Armata Pharmaceuticals Headline on 6th of September 2024
Acquisition by Brian Varnum of 298724 shares of Armata Pharm... by Brian Varnum
Filed transaction by Armata Pharmaceuticals Officer President And Cdo. Grant, award or other acquisition pursuant to Rule 16b-3
Akari Therapeutics Valuation on September 6, 2024
It is possible to determine the worth of Akari Therapeutics on a given historical date. On September 6, 2024 Akari was worth 3.45 at the beginning of the trading date compared to the closed value of 3.32. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Akari Therapeutics stock. Still, in general, we apply an absolute valuation method to find Akari Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Akari Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Akari Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 3.82 | 3.82 | 3.25 | 3.25 | 10,043 | |
09/06/2024 | 3.45 | 3.79 | 3.32 | 3.32 | 6,461 |
| 3.25 | 3.39 | 3.15 | 3.30 | 8,292 |
| Backtest Akari Therapeutics | | | Akari Therapeutics History | | | Akari Therapeutics Valuation | Previous | Next |
Akari Therapeutics Trading Date Momentum on September 6, 2024
| On September 09 2024 Akari Therapeutics PLC was traded for 3.30 at the closing time. The top price for the day was 3.39 and the lowest listed price was 3.15 . The trading volume for the day was 8.3 K. The trading history from September 9, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.60% . The overall trading delta against the current closing price is 3.92% . |
Akari Therapeutics PLC Fundamentals Correlations and Trends
By evaluating Akari Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Akari Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Akari financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Akari Therapeutics Stock history
Akari Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Akari is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Akari Therapeutics PLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Akari Therapeutics stock prices may prove useful in developing a viable investing in Akari Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.9 M | 4.7 M | |
| Net Loss | -20 M | -21 M |
Akari Therapeutics Stock Technical Analysis
Akari Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Akari Therapeutics Period Price Range
Low | November 26, 2024
| High |
0.00 | 0.00 |
Akari Therapeutics PLC cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Akari Therapeutics November 26, 2024 Market Strength
Market strength indicators help investors to evaluate how Akari Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Akari Therapeutics shares will generate the highest return on investment. By undertsting and applying Akari Therapeutics stock market strength indicators, traders can identify Akari Therapeutics PLC entry and exit signals to maximize returns
Akari Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Akari Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Akari Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Akari to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.19) | |||
| Jensen Alpha | (1.68) | |||
| Total Risk Alpha | (2.78) | |||
| Treynor Ratio | 3.44 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Akari Stock Analysis
When running Akari Therapeutics' price analysis, check to measure Akari Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akari Therapeutics is operating at the current time. Most of Akari Therapeutics' value examination focuses on studying past and present price action to predict the probability of Akari Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akari Therapeutics' price. Additionally, you may evaluate how the addition of Akari Therapeutics to your portfolios can decrease your overall portfolio volatility.